• SENSEX 82,733.65
    678.54 (+0.83%)
  • BANKNIFTY 56,461.90
    402.55 (+0.72%)
  • Garden Reach Sh.
    3,034.00 1,180.10(%)
  • Enviro Infra
    251.85 392.00(%)
  • Waaree Energies
    2,940.85 1,808.65(%)
  • Multi Comm. Exc.
    8,808.85 8,357.25(%)
  • Welspun Living
    142.00 213.10(%)
  • Vodafone Idea
    7.20 19.15(%)
  • M T N L
    57.90 101.88(%)
  • Bharat Electron
    409.00 240.15(%)
  • Sammaan Capital
    146.75 179.35(%)
  • Cochin Shipyard
    2,120.50 1,180.45(%)
  • Netwrk.18 Media
    61.82 106.01(%)
  • Mazagon Dock
    3,212.05 1,917.95(%)
  • Hind.Aeronautics
    4,791.50 3,045.95(%)
  • Dixon Technolog.
    14,055.70 10,613.00(%)
  • Hyundai Motor I
    2,145.00 2,083.60(%)
  • Vishal Mega Mart
    137.80 134.50(%)
  • Tata Motors
    678.80 1,179.05(%)
  • BEML Ltd
    4,422.00 2,346.35(%)
  • NTPC
    333.55 448.30(%)
  • Data Pattern
    2,805.00 1,350.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Akums Drugs & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 34484.0
  • ISIN : INE09XN01023
536.05 1 (0.21%)
  • As on 25 Jun 2025 (EOD)

  • Today’s Low

    532.60

  • Today’s High

    546.00

  • Open

    545.00

  • Perv Close

    534.95

  • 52W Low

    405.00

  • 52W High

    1,175.90

Key Indicators

  • P/E(TTM)

    52.45

  • Mar.Cap (₹Cr.)

    8,437.10

  • Div & Yield %

    0.00

  • Book Value(₹)

    146.52

  • Debt-Equity Ratio

    0.21

  • AGM Date

    24-Jun-2025

  • EPS

    10.23

  • P/E Ratio

    52.45

Financials Ratios

  • Debt-Equity Ratio

    0.83

  • Mar.Cap (₹Cr.)

    8,437.10

  • RONW (%)

    -3.57

  • ROCE (%)

    1.24

Score Board

  • Equity (₹ in Cr.)

    31.48

  • BV (₹)

    146.50

  • Sales( ₹ in Cr.)

    1,311.78

  • NP (in Cr.)

    161.00

  • NP Var(%)

    202.0

  • Div%

    0.0

  • CPS (₹)

    12.70

  • EPS (₹)

    10.20

  • Traded Value (₹ in Lakhs)

    8,445.76

  • 52 Week High

    1,175.90

  • 52 Week Low

    405.00

  • Price BSE

    537.0

  • Price NSE

    536.00

  • Market Capital( in Cr.)

    8,445.76

  • P/C Ratio

    42.10

  • P/E Ratio

    52.50

  • Price Vs.BV

    10.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,444.12 1,286.83 1,162.06 837.44 736.91 683.08
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,444.12 1,286.83 1,162.06 837.44 736.91 683.08
Other Income 94.12 96.15 58.48 54.51 65.52 56.87
Stock Adjustments -6.44 3.06 18.45 -10.64 -8.52 9.98
Total Income 1,531.80 1,386.04 1,238.99 881.31 793.91 749.93
EXPENDITURE :            
Raw Materials 867.24 791.21 786.51 513.05 457.83 427.59
Power and Fuel Cost 42.40 42.04 36.25 28.64 33.74 25.85
Employee Cost 175.28 147.30 136.37 122.65 123.70 103.11
Other Manufacturing Expenses 47.07 42.04 62.62 51.89 24.08 18.63
Selling and Administration Expenses 26.41 22.33 16.82 13.80 12.05 11.44
Miscellaneous Expenses 425.32 147.63 503.99 319.56 37.06 24.77
Employee Benefit Expenses 175.28 147.30 136.37 122.65 123.70 103.11
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,583.73 1,192.54 1,542.55 1,049.59 688.46 611.38
Operating Profit -51.93 193.50 -303.56 -168.28 105.45 138.54
Interest 18.31 13.18 3.65 0.82 4.34 3.63
Gross Profit -70.24 180.32 -307.21 -169.10 101.11 134.91
Depreciation 32.69 30.00 27.76 26.10 25.26 22.86
Profit Before Tax -102.93 150.32 -334.97 -195.20 75.85 112.05
Current Tax 48.34 41.00 0.34 6.40 23.61 37.56
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 14.18 -16.11 46.46 -56.17 1.38 -0.35
Reported Net Profit -165.45 125.43 -381.78 -145.43 50.86 74.84
Extraordinary Items -7.61 -105.11 0.99 -255.75 0.02 1.42
Adjusted Net Profit -157.84 230.54 -382.77 110.32 50.84 73.42
Adjustment below Net Profit -2.18 0.00 -11.62 0.16 0.00 0.00
P & L Balance brought forward 463.02 351.36 744.75 890.02 839.52 764.96
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 13.77 0.00 0.00 0.37 0.00
P & L Balance carried down 295.39 463.02 351.36 744.75 890.02 839.80
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -11.56 8.77 -53.37 -1,117.82 391.04 636.95
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 10.06 21.77 25.94 4,358.55 5,476.91 7,164.46
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    75.26%

  • Public Share Holding

    22.01%

  • Custodian

    2.73%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 54,255,380 34.47 54,255,380 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 64,200,000 40.79 64,200,000 1
Others 0 0.00 0 0
Sub Total 118,455,380 75.26 118,455,380 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,078,497 5.77 9,078,497 50
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,043,060 0.66 1,043,060 6
Mutual Funds / UTI 9,616,023 6.11 9,616,023 18
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 981,310 0.62 981,310 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,718,890 13.16 20,718,890 79
2] Non Institution
Bodies Corporate 871,163 0.55 871,163 197
Clearing Members 77 0.00 77 1
Directors of their Relatives 42 0.00 42 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 110,474 0.07 110,474 381
Foreign Non Institution Other 7,278,535 4.62 7,278,535 1
Hindu Undivided Families 222,815 0.14 222,815 1,534
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 5,372,820 3.41 5,372,820 67,137
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 308 0.00 308 1
Others 794 0.00 794 2
Sub Total 13,927,788 8.85 13,927,788 69,282
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 4,291,930 2.73 4,291,930 1
Total Shares held by Custodians and against which Depository Receipts have been issued 4,291,930 2.73 4,291,930 1
Grand Total ( A + B + C ) 157,393,988 100.00 157,393,988 69,366

Company Background

Akums Drugs & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Akums Drugs & Pharmaceuticals Ltd
  • BSE Code : 34484.0
  • ISIN : INE09XN01023

  • Incorporation Year

    2004

  • Registered Office

    304 Mohan Place LSC Saraswati
    Vihar, Delhi,
    Delhi-110034

  • Telephone

    +91 11 6904 1000

  • FAX

  • Chairman

  • Managing Director

    SANDEEP JAIN

  • Company Secretary

    Dharamvir Malik

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Akums Drugs & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Akums Drugs 536.60 1,538.24 1,444.12 52.45 -3.93
Abbott India 31,510.65 6,097.18 5,848.91 47.34 44.71
Astrazeneca Phar 8,798.50 1,330.33 1,295.53 190.03 33.26
P & G Health Ltd 5,912.35 1,166.89 1,151.26 39.07 39.76
Glaxosmi. Pharma 3,227.35 3,866.05 3,723.49 59.49 58.72
Cipla 1,502.85 20,029.57 19,044.85 23.53 21.40
Amrutanjan Healt 720.20 437.58 421.23 40.97 20.84
Guj. Themis Bio. 331.75 174.19 169.82 74.05 44.82
Fermenta Biotec. 305.00 315.24 307.09 13.28 4.10
Bliss GVS Pharma 148.60 638.96 605.46 22.69 11.19
Ambalal Sarabhai 35.73 11.70 3.81 33.08 1.92